Prostaglandin E2 modulation of blood pressure homeostasis: Studies in rodent models

Prostaglandins and Other Lipid Mediators

Volumn 96, Issue 1-4, 2011, Pages 10-13

  Swan, Christina E ^b   Breyer, Richard M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Blood pressure; EP receptors; GPCR; Hypertension; Kidney; Mouse; Prostaglandin E2; Rat

Indexed keywords

ANTIHYPERTENSIVE AGENT; G PROTEIN COUPLED RECEPTOR; ONOAE 1329; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; RENIN; SC 51322; UNCLASSIFIED DRUG; CALCIUM; CYCLIC AMP; VASOCONSTRICTOR AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; CHRONIC KIDNEY FAILURE; DRUG TARGETING; ESSENTIAL HYPERTENSION; GENE DELETION; HOMEOSTASIS; HORMONE ACTION; HUMAN; HYPERTENSION; NONHUMAN; PRESSOR RESPONSE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; KIDNEY; METABOLISM; MOUSE; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; RODENT;

ANIMALS; BLOOD PRESSURE; CALCIUM; CARDIOVASCULAR DISEASES; CYCLIC AMP; DINOPROSTONE; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; KIDNEY; KIDNEY FAILURE, CHRONIC; MICE; MICE, KNOCKOUT; PROSTAGLANDIN ANTAGONISTS; RATS; RECEPTORS, PROSTAGLANDIN E; RENIN-ANGIOTENSIN SYSTEM; RODENTIA; SIGNAL TRANSDUCTION; VASOCONSTRICTOR AGENTS;

EID: 81155133955     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2011.07.001     Document Type: Review

References (39)

1. J.M. Flack Epidemiology and unmet needs in hypertension J Manag Care Pharm 13 2007 2 8
2. C.R. Kennedy, Y. Zhang, and S. Brandon Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor Nat Med 5 1999 217 220 (Pubitemid 29068530)
3. T.K. Schaaf, and H.J. Hess Synthesis and biological activity of carboxyl-terminus modified prostaglandin analogues J Med Chem 22 1979 1340 1346 (Pubitemid 10193600)
4. G.M. Hockel, and A.W. Cowley Prostaglandin E2-induced hypertension in conscious dogs Am J Physiol 237 1979 H449 H454
5. L.P. Audoly, S.L. Tilley, and J. Goulet Identification of specific EP receptors responsible for the hemodynamic effects of PGE2 Am J Physiol 277 1999 H924 H930
6. S.L. Tilley, L.P. Audoly, and E.H. Hicks Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor J Clin Invest 103 1999 1539 1545
7. M.D. Breyer, and R.M. Breyer Prostaglandin E receptors and the kidney Am J Physiol Renal Physiol 279 2000 F12 F23
8. Y. Zhang, Y. Guan, A. Schneider, S. Brandon, R.M. Breyer, and M.D. Breyer Characterization of murine vasopressor and vasodepressor prostaglandin E(2) receptors Hypertension 35 2000 1129 1134 (Pubitemid 30327269)
9. L.P. Audoly, X. Ruan, and V.A. Wagner Role of EP(2) and EP(3) PGE(2) receptors in control of murine renal hemodynamics Am J Physiol Heart Circ Physiol 280 2001 H327 H333
10. Y. Guan, Y. Zhang, and J. Wu Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting J Clin Invest 117 2007 2496 2505 (Pubitemid 47494351)
11. J.H. Gurwitz, J. Avorn, R.L. Bohn, R.J. Glynn, M. Monane, and H. Mogun Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy JAMA 272 1994 781 786
12. M. Imanishi, M. Kawamura, and S. Akabane Aspirin lowers blood pressure in patients with renovascular hypertension Hypertension 14 1989 461 468 (Pubitemid 19270509)
13. P.J. Jakobsson, S. Thorén, R. Morgenstern, and B. Samuelsson Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target Proc Natl Acad Sci USA 96 1999 7220 7225 (Pubitemid 29299642)
14. C.S Facemire, R. Griffiths, L.P. Audoly, B.H. Koller, and T.M. Coffman The impact of microsomal prostaglandin E synthase 1 on blood pressure is determined by genetic background Hypertension 55 2010 531 538
15. D.J. Zhang, L.H. Chen, and Y.H. Zhang Enhanced pressor response to acute Ang II infusion in mice lacking membrane-associated prostaglandin E2 synthase-1 Acta Pharmacol Sin 31 2010 1284 1292
16. Z. Jia, T. Aoyagi, and T. Yang mPGES-1 protects against DOCA-salt hypertension via inhibition of oxidative stress or stimulation of NO/cGMP Hypertension 55 2010 539 546
17. L. Ruilope, R. Garcia Robles, and A. Barrientos The role of urinary PGE2 and renin-angiotensin-aldosterone system in the pathogenesis of essential hypertension Clin Exp Hypertens A 4 1982 989 1000 (Pubitemid 13228007)
18. R.A. Coleman, W.L. Smith, and S. Narumiya International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes Pharmacol Rev 46 1994 205 229 (Pubitemid 24185151)
19. J.B Regard, I.T. Sato, and S.R. Coughlin Anatomical profiling of G protein-coupled receptor expression Cell 135 2008 561 571
20. Y. Sugimoto, and S. Narumiya Prostaglandin E receptors J Biol Chem 282 2007 11613 11617 (Pubitemid 47100657)
21. J.I. Kim, V. Lakshmikanthan, N. Frilot, and Y. Daaka Prostaglandin E2 promotes lung cancer cell migration via EP4-betaArrestin1-c-Src signalsome Mol Cancer Res 8 2010 569 577
22. K.S. Chun, H.C. Lao, and R. Langenbach The prostaglandin E2 receptor, EP2, stimulates keratinocyte proliferation in mouse skin by G protein-dependent and {beta}-arrestin1-dependent signaling pathways J Biol Chem 285 2010 39672 39681
23. B. Eklund, and L.A. Carlson Central and peripheral circulatory effects and metabolic effects of different prostaglandins given I.V. to man Prostaglandins 20 1980 333 347 (Pubitemid 10024260)
24. M.D. Murray, P.K. Greene, D.C. Brater, A.K. Manatunga, and S.D. Hall Effects of flurbiprofen on renal function in patients with moderate renal insufficiency Br J Clin Pharmacol 33 1992 385 393
25. A.G. Johnson NSAIDs and increased blood pressure. What is the clinical significance? Drug Saf 17 1997 277 289 (Pubitemid 27496848)
26. H.F. Cheng, and R.C. Harris Cyclooxygenases, the kidney, and hypertension Hypertension 43 2004 525 530 (Pubitemid 38282421)
27. D.H Solomon, S. Schneeweiss, R. Levin, and J. Avorn Relationship between COX-2 specific inhibitors and hypertension Hypertension 44 2004 140 145 (Pubitemid 39014229)
28. A. Mori, M. Saito, K. Sakamoto, M. Narita, T. Nakahara, and K. Ishii Stimulation of prostanoid IP and EP(2) receptors dilates retinal arterioles and increases retinal and choroidal blood flow in rats Eur J Pharmacol 570 2007 135 141 (Pubitemid 47248666)
29. A.M. Hristovska, L.E. Rasmussen, and P.B. Hansen Prostaglandin E2 induces vascular relaxation by E-prostanoid 4 receptor-mediated activation of endothelial nitric oxide synthase Hypertension 50 2007 525 530 (Pubitemid 47312239)
30. M. Nguyen, T. Camenisch, and J.N. Snouwaert The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth Nature 390 1997 78 81 (Pubitemid 27494759)
31. T.J. Jensen, and O.A. Nedergaard Modulation of norepinephrine release from sympathetic neurons of the rabbit aorta by prejunctional prostanoid receptors J Pharmacol Exp Ther 291 1999 7 11 (Pubitemid 29451566)
32. H. Ariumi, Y. Takano, and A. Masumi Roles of the central prostaglandin EP3 receptors in cardiovascular regulation in rats Neurosci Lett 324 2002 61 64 (Pubitemid 34442678)
33. J.L. Stock, K. Shinjo, and J. Burkhardt The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure J Clin Invest 107 2001 325 331 (Pubitemid 32157964)
34. M. Wang, K. Ihida-Stansbury, and D. Kothapalli Microsomal prostaglandin e2 synthase-1 modulates the response to vascular injury Circulation 123 2011 631 639
35. M. Wang, E. Lee, and W. Song Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation Circulation 117 2008 1302 1309 (Pubitemid 351365673)
36. M. Wang, W.L. Song, Y. Cheng, and G.A. Fitzgerald Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease J Intern Med 263 2008 500 505 (Pubitemid 351533553)
37. T. Suganami, K. Mori, and I. Tanaka Role of prostaglandin E receptor EP1 subtype in the development of renal injury in genetically hypertensive rats Hypertension 42 2003 1183 1190 (Pubitemid 37549075)
38. C. Capone, G. Faraco, J. Anrather, P. Zhou, and C. Iadecola Cyclooxygenase 1-derived prostaglandin E2 and EP1 receptors are required for the cerebrovascular dysfunction induced by angiotensin II Hypertension 55 2010 911 917
39. C.Y. Xiao, K. Yuhki, and A. Hara Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4 Circulation 109 2004 2462 2468 (Pubitemid 38679568)